Table 1. Patient Characteristics and... | American Society of Hematology

Table 1.

Patient Characteristics and Mobilization

Patient No.	Diagnosis	Age (yr)	Prior Chemo	Prior Radiotherapy	Total Collected CD34⁺/kg (×10⁶)	No. of Apheresis
Study group
1	NHL	23	Yes^*	No	8.5	2
2	NHL	42	Yes^*	No	5.0	2
3	BC	49	Yes^†	No	10.9	1
4	BC	48	Yes^†	No	14.1	1
5	BC	31	Yes^†	No	9.1	1
6	BC	48	Yes^†	No	6.7	2
7	BC	47	Yes^†	No	16.5	1
8	BC	57	Yes^†	No	10.2	1
9	BC	46	Yes^†	Yes	5.2	1
10	BC	53	Yes^†	No	5.7	2
Mean ± 1SD		44 ± 10			9.1 ± 3.8
Control group
1	NHL	39	Yes^*	No	7.5	2
2	NHL	29	Yes^*	No	12.1	2
3	BC	43	Yes^†	No	9.3	3
4	BC	45	Yes^†	No	7.8	1
5	BC	48	Yes^†	No	9.8	2
6	BC	32	Yes^†	No	10.4	1
7	BC	54	Yes^†	No	5.1	2
8	BC	47	Yes^†	No	5.6	3
9	BC	48	Yes^†	No	10.0	2
10	BC	52	Yes^†	No	7.2	3
11	BC	47	Yes^†	No	6.0	2
12	BC	53	Yes^†	No	8.6	2
13	BC	41	Yes^†	No	11.0	2
14	BC	51	Yes^†	No	8.4	2
Mean ± 1SD		41 ± 13			8.4 ± 2.1

Patient No.	Diagnosis	Age (yr)	Prior Chemo	Prior Radiotherapy	Total Collected CD34⁺/kg (×10⁶)	No. of Apheresis
Study group
1	NHL	23	Yes^*	No	8.5	2
2	NHL	42	Yes^*	No	5.0	2
3	BC	49	Yes^†	No	10.9	1
4	BC	48	Yes^†	No	14.1	1
5	BC	31	Yes^†	No	9.1	1
6	BC	48	Yes^†	No	6.7	2
7	BC	47	Yes^†	No	16.5	1
8	BC	57	Yes^†	No	10.2	1
9	BC	46	Yes^†	Yes	5.2	1
10	BC	53	Yes^†	No	5.7	2
Mean ± 1SD		44 ± 10			9.1 ± 3.8
Control group
1	NHL	39	Yes^*	No	7.5	2
2	NHL	29	Yes^*	No	12.1	2
3	BC	43	Yes^†	No	9.3	3
4	BC	45	Yes^†	No	7.8	1
5	BC	48	Yes^†	No	9.8	2
6	BC	32	Yes^†	No	10.4	1
7	BC	54	Yes^†	No	5.1	2
8	BC	47	Yes^†	No	5.6	3
9	BC	48	Yes^†	No	10.0	2
10	BC	52	Yes^†	No	7.2	3
11	BC	47	Yes^†	No	6.0	2
12	BC	53	Yes^†	No	8.6	2
13	BC	41	Yes^†	No	11.0	2
14	BC	51	Yes^†	No	8.4	2
Mean ± 1SD		41 ± 13			8.4 ± 2.1

Sequential chemotherapy including CTX, MTX, VCR, EPI, VP-16.

Sequential chemotherapy including CTX, MTX, VCR, EPI.